Latest News

Japan flag in Tokyo | Image credit: Savvapanf Photo © -
Alvotech’s Stelara Biosimilar Approved in Japan

September 25th 2023

Iceland-based Alvotech announced the approval of its ustekinumab biosimilar referencing Stelara in Japan for autoimmune conditions. The company also released an update on the US filing for its adalimumab biosimilar.

a graphic of arthritis in hands
Link Between Antidrug Antibodies and bDMARDs Nonresponse in Patients With RA

September 11th 2023

globe and an atom
Regulatory Updates From Around the Globe Provide Hope for Biosimilars

September 9th 2023

doctor filling syringe | natali_mis -
The Growth of Biosimilars Continues to Create Hope for Lower Drug Costs

September 7th 2023

syringe shimmer
Alvotech Earnings Jump Nearly 600% Year Over Year

September 2nd 2023

Video Interviews
CfB podcast banner
CFB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.